Predicting the function and subcellular location of Caenorhabditis elegans proteins similar to Saccharomyces cerevisiae beta-oxidation enzymes.
The role of peroxisomal processes in the maintenance of neurons has not been thoroughly investigated. We propose using Caenorhabditis elegans as a model organism for studying the molecular basis underlying neurodegeneration in certain human peroxisomal disorders, e.g. Zellweger syndrome, since the nematode neural network is well characterized and relatively simple in function. Here we have identified C. elegans PEX-5 (C34C6.6) representing the receptor for peroxisomal targeting signal type 1 (PTS1), defective in patients with such disorders. PEX-5 interacted strongly in a two-hybrid assay with Gal4p-SKL, and a screen using PEX-5 identified interaction partners that were predominantly terminated with PTS1 or its variants. A list of C. elegans proteins with similarities to well-characterized yeast beta-oxidation enzymes was compiled by homology probing. The possible subcellular localization of these orthologues was predicted using an algorithm based on trafficking signals. Examining the C termini of selected nematode proteins for PTS1 function substantiated predictions made regarding the proteins' peroxisomal location. It is concluded that the eukaryotic PEX5-dependent route for importing PTS1-containing proteins into peroxisomes is conserved in nematodes. C. elegans might emerge as an attractive model system for studying the importance of peroxisomes and affiliated processes in neurodegeneration, and also for studying a beta-oxidation process that is potentially compartmentalized in both mitochondria and peroxisomes.
Gurvitz
A
A
Institut für Biochemie und Molekulare Zellbiologie der Universität Wien and Ludwig Boltzmann Forschungsstelle für Biochemie, Vienna Biocenter, Dr Bohrgasse 9, A-1030 Vienna, Austria. AG@abc.univie.ac.at
Langer
S
S
Piskacek
M
M
Hamilton
B
B
Ruis
H
H
Hartig
A
A
D042962:Acyl-CoA Oxidase; D000465:Algorithms; D000818:Animals; D017173:Caenorhabditis elegans / Q000201:enzymology*; D004798:Enzymes / Q000737:chemistry / Q000378:metabolism*; D005544:Forecasting; D005656:Fungal Proteins / Q000737:chemistry; D015801:Helminth Proteins / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007535:Isomerases / Q000737:chemistry / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000737:chemistry; D010455:Peptides / Q000378:metabolism; D018901:Peroxisomal Disorders / Q000503:physiopathology; D020675:Peroxisomes / Q000201:enzymology*; D011956:Receptors, Cell Surface / Q000235:genetics / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000201:enzymology* / Q000235:genetics / Q000254:growth & development; D029701:Saccharomyces cerevisiae Proteins; D013347:Subcellular Fractions / Q000201:enzymology; D020798:Two-Hybrid System Techniques
D004798:Enzymes; C400127:FOX2 protein, Glomus mosseae; D005656:Fungal Proteins; D015801:Helminth Proteins; D008565:Membrane Proteins; D010455:Peptides; D011956:Receptors, Cell Surface; D029701:Saccharomyces cerevisiae Proteins; C085380:peroxisomal targeting sequence receptor; D010088:Oxidoreductases; D042962:Acyl-CoA Oxidase; C467991:POX1 protein, S cerevisiae; D007535:Isomerases